Walled Lake Planning & Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
– Sell
-164
Closed -$10K – 321
2020
Q3
$10K Buy
164
+1
+0.6% +$60 0.01% 211
2020
Q2
$10K Buy
+163
New +$9.75K 0.01% 197

Other funds holding BMY

Walled Lake Planning & Wealth Management's BMY Position: Q4 2020 in Review

Walled Lake Planning & Wealth Management sold out of Bristol-Myers Squibb (BMY) in Q4 2020, closing a stake of 164 shares — an estimated $10K sold.

Walled Lake Planning & Wealth Management first reported a position in BMY in Q2 2020 and held it in 2 quarters. The position peaked at $10K in Q3 2020. 2,362 funds tracked by Wall St. Rank hold BMY as of Q4 2020.

  • Walled Lake Planning & Wealth Management reported no remaining Bristol-Myers Squibb position as of Q4 2020 after selling out during the quarter.
  • Walled Lake Planning & Wealth Management sold 164 Bristol-Myers Squibb shares in Q4 2020, an estimated $10K.
  • Walled Lake Planning & Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2020 and held it in 2 quarters.
  • Walled Lake Planning & Wealth Management's Bristol-Myers Squibb position peaked at $10K in Q3 2020.
  • 2,362 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2020.

Based on Walled Lake Planning & Wealth Management's 13F filing for Q4 2020, filed 19 Feb 2021.